🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ken Cheng

National Institutes of Health

ORCID: 0000-0003-0437-5697

Also affiliated with National Center for Advancing Translational Sciences

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer”.

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Science Translational Medicine(2023)10.1126/scitranslmed.add7872
N/A
0.790DataRank · unranked
25 citations

Tzu‐Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert +12 more

Myopic Shift at 10-Year Follow-up in the Infant Aphakia Treatment Study

Ophthalmology(2022)10.1016/j.ophtha.2022.04.004
N/A
0.572DataRank · unranked
13 citations

Azhar Nizam, Deborah K. VanderVeen, M. Edward Wilson, Stacy Kruger, Scott R. Lambert +78 more

Distinct effects of sacituzumab govitecan and berzosertib on DNA damage response in ovarian cancer

iScience(2024)10.1016/j.isci.2024.111283
N/A
0.312DataRank · unranked
7 citations

Tzu‐Ting Huang, Anu D. Sunkara, Margaret R. Pruitt, Kristen R. Ibanez, Chih-Yuan Chiang +6 more

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer

medRxiv(2022)10.1101/2022.12.02.22283037
N/A
0DataRank · unranked
2 citations

Tzu‐Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert +12 more

AKT1 interacts with DHX9 to Mitigate R Loop–Induced Replication Stress in Ovarian Cancer

Cancer Research(2024)10.1158/0008-5472.can-23-1908
N/A
0DataRank · unranked
28 citations

Chih-Yuan Chiang, Jayakumar R. Nair, Kelli M. Wilson, Ken Cheng, Jung‐Min Lee +1 more

Genome-Wide High-Throughput RNAi Screening for Identification of Genes Involved in Protein Production

Methods in molecular biology(2024)10.1007/978-1-0716-3878-1_20
N/A
0DataRank · unranked
0 citations

Ken Cheng, Michael J. Betenbaugh, Joseph Shiloach, Sarah Inwood

High-throughput screening identifies Aurora kinase B as a critical therapeutic target for Merkel cell carcinoma

Nature Communications(2025)10.1038/s41467-025-56504-7
N/A
0DataRank · unranked
5 citations

Khalid A. Garman, Daniel J. Urban, Amy Coxon, Berkley E. Gryder, Natasha T. Hill +17 more

Protein Phosphatase 1 Regulatory Subunit PNUTS Prevents CENP-A Mislocalization and Chromosomal Instability

Molecular and Cellular Biology(2025)10.1080/10985549.2025.2487010
N/A
0DataRank · unranked
2 citations

Makenzie Thomas, Roshan L. Shrestha, Subhash Chandra Sethi, Raj Chari, Shinjen Lin +5 more

Chromatin remodeling activity of EP400 safeguards chromosomal stability by preventing CENP-A mislocalization

Cell Reports(2025)10.1016/j.celrep.2025.116423
N/A
0DataRank · unranked
1 citations

Roshan L. Shrestha, Vinutha Balachandra, Tetsuya Hori, Luca Corda, Shinjen Lin +11 more

Evaluation of 11C-NR2B-SMe and Its Enantiomers as PET Radioligands for Imaging the NR2B Subunit Within the NMDA Receptor Complex in Rats

Journal of Nuclear Medicine(2020)10.2967/jnumed.119.235143
N/A
0DataRank · unranked
22 citations

Jeih‐San Liow, Cheryl L. Morse, Sanjay Telu, Riley Davies, Michael P. Frankland +6 more

A genome-wide siRNA screen identifies previously unknown proviral and antiviral host factors in HBV infection

Journal of Hepatology(2025)10.1016/j.jhep.2025.11.017
N/A
0DataRank · unranked
1 citations

Yuchen Xia, Chen Li, Min Zhang, Tadashi Inuzuka, Sirisha Chakka +9 more

SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243

Cancer Research(2021)10.1158/0008-5472.can-20-2694
N/A
0DataRank · unranked
55 citations

Ukhyun Jo, Junko Murai, Lisa M. Jenkins, Shar-yin N. Huang, Sirisha Chakka +6 more

Genome-Edited Coincidence and PMP22-HiBiT Fusion Reporter Cell Lines Enable an Artifact-Suppressive Quantitative High-Throughput Screening Strategy for PMP22 Gene-Dosage Disorder Drug Discovery

ACS Pharmacology & Translational Science(2021)10.1021/acsptsci.1c00110
N/A
0DataRank · unranked
9 citations

John Braisted, Patricia Dranchak, John J. Moran, Hunter G. Larson, Bryan Queme +7 more